|
|
|
|
|
Champions Oncology Inc (CSBR) |
|
|
|
| |
Champions Oncology Inc 's Yearly Free Cash Flow Growth 5 Years |
| |
|
Select the Comparisons :
|
|
Select the Ratio:
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
Annual Free Cash Flow Annual Growth Rates Y/Y▼
|
CSBR Annual Free Cash Flow Growth |
2023
|
2022
|
2021
|
2020
|
2019
|
| Y / Y Annual Free Cash Flow Change |
-73.26 % |
- |
- |
-33.37 % |
- |
| Annual Free Cash Flow (in millions $) |
$1.10 |
$4.11 |
$-4.96 |
$0.69 |
$1.03 |
| Annual Free Cash Flow Growth
Comment |
Champions Oncology Inc experienced detoriation of Annual Free Cash Flow for the fiscal year ended 2023 by -73.26% to $ 1.10 millions, compare to $ 4.11 in Annual Free Cash Flow reported in the previous year. Champions Oncology Inc 's Free Cash Flow decline slowed form -182.89 % contraction in the fiscal year 2022.
Champions Oncology Inc Annual Income Statement
|
|
You need to upgrade your Flash Player
|
| Companies with similar 2023 Annual Free Cash Flow within Healthcare Sector | Y/Y Free Cash Flow Growth % | 2023 Annual Free Cash Flow | | Inhibitor Therapeutics Inc | | | |
